Array BioPharma To Present At The Stifel Nicolaus Healthcare, NewsMakers In The Biotech Industry And Morgan Stanley Global Healthcare Conferences

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the following upcoming conferences. The public is welcome to participate in the conferences through webcasts on the Array BioPharma website: www.arraybiopharma.com.

Event:
  Stifel Nicolaus Healthcare Conference

Date:
Thursday, September 6, 2012

Time:
9:45 a.m. Eastern Time

Location:
Four Seasons, Boston, MA
 

Event:
NewsMakers in the Biotech Industry Conference

Date:
Friday, September 7, 2012

Time:
8:30 a.m. Eastern Time

Location:
Millennium Broadway Hotel, New York, NY
 

Event:
Morgan Stanley Global Healthcare Conference

Date:
Monday, September 10. 2012

Time:
10:35 a.m. Eastern Time

Location:

Grand Hyatt, New York, NY

About Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small-molecule drugs to treat patients afflicted with cancer. Array is evolving into a late-stage development company, with two wholly-owned programs, ARRY-614 and ARRY-520, and three partnered programs, selumetinib partnered with AstraZeneca, MEK162 partnered with Novartis, and danoprevir, partnered with InterMune / Roche, having the potential to begin Phase 3 or pivotal trials by the end of calendar year 2013. For more information on Array, please go to www.arraybiopharma.com.

If you liked this article you might like

STMicroelectronics, Intercept Pharmaceuticals: 'Mad Money' Lightning Round

Watch Out For the Dominoes That Fall: Cramer's 'Mad Money' Recap (Wed 9/20/17)

Mirati Skyrockets On Positive Data - Biotech Movers

Array BioPharma Seems to Be in a New Uptrend